Martin Currie LTD Cut Pfizer INC (PFE) Holding by $6.07 Million

Marco Green
December 5, 2017

K.J. Harrison & Partners Inc now owns 48,639 shares of the biopharmaceutical company's stock worth $1,664,000 after purchasing an additional 5,159 shares during the last quarter. Ig Management holds 1.72% or 9.93 million shares in its portfolio. Pfizer Inc now has $214.94B valuation. The stock increased 0.39% or $0.14 during the last trading session, reaching $36.49. (NYSE:PFE). Standard Life Investments reported 0.89% of its portfolio in Pfizer Inc. It has underperformed by 19.46% the S&P500. Ross Stores Inc now has $30.08B valuation. The company has market cap of $37.72 million. It offers Control4 solution that functions as the operating system of the home, integrating audio, video, lighting, temperature, security, communications, and other devices in the home automation market. It has a 7.05 P/E ratio. It also provides agricultural loans; commercial and industrial loans, including working capital and other shorter-term lines of credit, and fixed-rate loans; commercial real estate loans comprising owner-occupied and non-owner-occupied CRE loans, multifamily residential real estate loans, and construction and development loans; short-term working capital funding, long-term land-related lending, and other tailored services; and residential mortgage loans, home equity loans, home equity lines of credit and general lines of credit, and auto loans and other loans. The correct version of this article can be viewed at (NYSE:PFE) for 554,750 shares. Beaumont Financial Partners LLC lifted its stake in shares of Pfizer by 17.1% during the 1st quarter. Duncker Streett & Incorporated holds 0.96% of its portfolio in Pfizer Inc. With 22.15 price-earnings Pfizer trading in overbought territory and current trends indicate investors might be overpricing Pfizer Inc. stock, thought its expensive investors sentiments points to buy. Its down 0.01, from 0.95 in 2017Q1. The stock grabbed 76 new institutional investments totaling 21,498,647 shares while 64 institutional investors sold out their entire positions totaling 8,652,931 shares. 112 funds opened positions while 612 raised stakes. Hallmark Cap Mgmt reported 0.25% stake. Driehaus Capital Mgmt Limited Liability Co stated it has 15,097 shares or 0.02% of all its holdings. Georgia-based Crawford Counsel has invested 0.53% in Pfizer Inc. The biopharmaceutical company reported $0.69 earnings per share for the quarter, beating analysts' consensus estimates of $0.67 by $0.02. Cambridge, Nebraska-based fund reported 14,874 shares. Inc. grew its stake in Pfizer by 67.0% in the second quarter. (NYSE:PFE). Schroder Management Group reported 0.87% stake. Kempner Management invested 1.24% in Pfizer Inc. Moreover, Magellan Asset Management Limited has 0% invested in Pfizer Inc. (NYSE:PFE). Thompson Siegel And Walmsley Lc reported 0.16% in Pfizer Inc. (NYSE:PFE) for 329,252 shares. 499,504 were reported by Azimuth Capital Management Llc. Fairview Capital Invest Ltd Liability holds 6,790 shares.

Pfizer (NYSE:PFE) last posted its quarterly earnings data on Tuesday, May 2nd. Therefore 90% are positive.

According to Zacks, analysts expect that Pfizer will report full-year earnings of $2.59 per share for the current financial year, with EPS estimates ranging from $2.57 to $2.60. The brokerage now has a buy rating on the biopharmaceutical company's stock. Investors will get a clear idea on how much they can earn per share on each of the outstanding shares of common stock. BMO Capital Markets maintained Pfizer Inc. The rating was maintained by Piper Jaffray with "Overweight" on Friday, August 28. The stock has "Buy" rating by Jefferies on Thursday, April 7. Morgan Stanley upgraded Pfizer from an "equal weight" rating to an "overweight" rating and upped their price objective for the stock from $35.00 to $39.00 in a research note on Wednesday, September 20th. Cowen & Co maintained Pfizer Inc.

Adell Harriman & Carpenter Inc increased Gs Emerging Market Etf stake by 4,100 shares to 29,800 valued at $930.95 million in 2017Q2. The company was maintained on Tuesday, September 13 by Jefferies. 12, 2017. The company's shares were given away at $35 per share worth to an income of some $1,338,050 on account of Susman Sally. The stock has "Buy" rating by Cowen & Co on Monday, September 18. The firm has "Neutral" rating by Societe Generale given on Friday, March 24. About 5,359 shares traded. It also reduced its holding in Comcast (NASDAQ:CMCSA) by 374,803 shares in the quarter, leaving it with 10.38M shares, and cut its stake in Luxoft Holding (NYSE:LXFT). Ishares 60 (MCHI) was raised too. State Street Corporation invested in 0.94% or 316.52 million shares. Following the completion of the sale, the insider now directly owns 117,432 shares in the company, valued at $4,145,349.60. Auxier Asset invested in 0.59% or 85,668 shares. The Massachusetts-based Bogle Investment Management L P De has invested 0.39% in the stock.

Analysts await KMG Chemicals, Inc.

Ratings analysis reveals 50% of Control4's analysts are positive. One analyst has rated the stock with a sell rating, ten have issued a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company. The stock has "Outperform" rating by Raymond James on Friday, February 10. BMO Capital Markets has "Buy" rating and $39.0 target.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Other reports by Click Lancashire

Discuss This Article